Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05732532
PHASE4

Steroids in Occipital Nerve Block for Treatment of Headache

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

Currently there is limited evidence of benefit for the addition of steroids to occipital nerve blocks for treatment of headache, and not all steroids have been explored. The purpose of this research is to learn more about whether the addition of a specific kind of steroid (dexamethasone) provides any additional benefit to nerve blocks.

Official title: Treatment of Headache With Occipital Nerve Blocks: Comparison Trial of Anesthetic With or Without Dexamethasone

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2023-02-17

Completion Date

2025-06-01

Last Updated

2026-06-24

Healthy Volunteers

No

Interventions

DRUG

Bupivacaine

2 mL of bupivacaine 0.5% (5 mg/mL) injected at the origin of each bilateral greater and lesser occipital nerves

DRUG

Lidocaine

0.5 mL of lidocaine 1% (10 mg/mL) injected at the origin of each bilateral greater and lesser occipital nerves

DRUG

Dexamethasone

0.5 mL of dexamethasone (10 mg/mL) injected at the origin of each bilateral greater and lesser occipital nerves

DRUG

Normal saline

0.5 mL of normal saline 0.9% injected at the origin of each bilateral greater and lesser occipital nerves

PROCEDURE

Greater/lesser occipital nerve blocks

Subjects will receive a total of 12 mL injectate divided equally between the 4 injection sites of the bilateral greater and lesser occipital nerves using the landmark-based technique.

Locations (1)

Mayo Clinic Minnesota

Rochester, Minnesota, United States